Brief: Index Pharmaceuticals Says Co Has Entered Into A Conditional Agreement Regarding A Reverse Merger With Flerie

Flerie AB

20/05/2024 20:02

May 20 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS HAS ENTERED INTO A CONDITIONAL
AGREEMENT
REGARDING A REVERSE MERGER WITH FLERIE
    * FLERIE INVEST AB'S SHAREHOLDERS WILL INITIALLY HOLD
APPROXIMATELY 91.9 PER CENT OF SHARES
    * THROUGH CAPITAL RAISE, COMPANY WILL RAISE IN AGGREGATE
APPROXIMATELY MSEK 520 BEFORE TRANSACTION COSTS.
    * CO'S EXISTING SHAREHOLDERS WILL INITIALLY HOLD
APPROXIMATELY 8.1
PER CENT OF SHARES IN COMPANY.
    * AS A RESULT OF TRANSACTION, COMPANY WILL CHANGE ITS NAME
TO
FLERIE AB ("NEW FLERIE")
    * INDEX PHARMACEUTICALS  - FOURTH SWEDISH NATIONAL PENSION
FUND,
REPRESENTING APPROX 9.8 PER CENT INTENDS TO VOTE IN FAVOUR OF
TRANSACTION

Source text for Eikon:  ID:nWkr3b2hKp 
Further company coverage:  INDEX.ST 

 ((Reuters.Briefs@thomsonreuters.com;))